先進創傷ケアの世界市場...市場調査レポートについてご紹介

1. Analyst View
2. Research Methodology
3. An Introduction
3.1 Types of Wounds
3.1.1 Ulcers
3.1.2 Burns
3.1.3 Surgical Wounds
3.2 Advanced Wound Care (AWC) – Products and Technologies
3.2.1 Film Dressings
3.2.2 Foam Dressings
3.2.3 Collagen
3.2.4 Alginates
3.2.5 Hydrocolloids
3.2.6 Hydrogels
3.2.7 Oxygen and Hyperbaric Oxygen Equipment
3.2.8 Electromagnetic Therapy Devices
3.2.9 Negative Pressure Wound Therapy
4. Drivers and Challenges
4.1 Significant Benefits over Traditional Counterparts to Drive the Growth of AWC
4.2 Increased Hospital Adoption of AWC to Boost the Market
4.3 Rising Incidence of Diabetes to Spur Market Growth
4.4 Shrinking Healthcare Budgets and Low Reimbursement Act as Major Hurdles for AWC
5. Market Overview
5.1 Global Wound Care Market
5.2 Global Advanced Wound Care Market
6. Market Trends and Developments
6.1 Rise in Adoption of Hyperbaric Oxygen Therapy
6.2 Peptide Bioactives: The next ‘it’ thing in the field of AWC
6.3 Smart Dressings: Adding a New Dimension to Wound Healing
6.4 Taking Wound Care to a New Level with Nanotechnology
7. Competitive Landscape
7.1 Share of Major Players in the AWC Market
7.2 Profiles
7.2.1 Convatec
7.2.2 Centaur Guernsey L.P. Inc.
7.2.3 Smith & Nephew
7.2.4 Mölnlycke Health Care
7.2.5 Coloplast
7.2.6 Hartmann Group
7.2.7 Derma Sciences
7.2.8 Integra LifeSciences
8. Future Outlook

List of Figures:

Figure 4-1: Global – Wound Care Market (Billion US$), 2013-2018
Figure 4-2: Global – Wound Care Market by Geography (%), 2013
Figure 4-3: Global – Wound Care Market by Geography (%), 2018
Figure 4-4: Global – Advanced Wound Care Market (Billion US$), 2013-2018
Figure 4-5: Global – Share of AWC in the Total Wound Care Market (%), 2013 & 2018
Figure 4-6: Global – AWC Market by Product Segment (%), 2013
Figure 7-1: Convatec – Break up of Revenue by Industry Segment (%), 2013
Figure 7-2: Convatec – AWC Revenue (Million US$), 2011-2013
Figure 7-3: Centaur Guernsey – Break up of Revenue by Industry Segment (%), 2013
Figure 7-4: Centaur Guernsey – Break up of Revenue by Geographic Segment (%), 2013
Figure 7-5: Centaur Guernsey – AWC Revenue (Billion US$), 2011-2013
Figure 7-6: Smith & Nephew – Break up of Revenue by Geographic Segment (%), 2013
Figure 7-7: Smith & Nephew – Break up of Revenue by Industrial Segment (%), 2013
Figure 7-8: Smith & Nephew – Break up of AWC Revenue by Segment (%), 2013
Figure 7-9: Smith & Nephew – AWC Revenue (Billion US$), 2011-2013
Figure 7-10: Coloplast – Break up of Revenue by Geographic Segment (%), 2013
Figure 7-11: Coloplast – Break up of Revenue by Industrial Segment (%), 2013
Figure 7-12: Coloplast – AWC Revenue (Billion DKK), 2011-2013
Figure 7-13: Hartmann Group – Break up of Revenue by Industrial Segment (%), 2013
Figure 7-14: Hartmann Group – Break up of Revenue by Geographical Segment (%), 2013
Figure 7-15: Integra LifeSciences – Break up of Revenue by Geographical Segment (%), 2013
Figure 7-16: Integra LifeSciences – Break up of US Revenue by Industrial Segment (%), 2013

List of Tables:

Table 3-1: Benefits of Advanced Wound Care
Table 7-1: Global – Share of Major Players in the AWC Market (%), 2013
Table 7-2: Convatec – Key Financials (Million US$), 2011-2013
Table 7-3: Convatec – Strengths and Weaknesses
Table 7-4: Centaur Guernsey – Key Financials (Million US$), 2011-2013
Table 7-5: Centaur Guernsey – Strengths and Weaknesses
Table 7-6: Smith & Nephew – Key Financials (Million US$), 2011-2013
Table 7-7: Smith & Nephew – Strengths and Weaknesses
Table 7-8: Mölnlycke Health Care – Strengths and Weaknesses
Table 7-9: Coloplast – Key Financials (Million DKK), 2011-2013
Table 7-10: Coloplast – Strengths and Weaknesses
Table 7-11: Hartmann Group – Key Financials (Million EUR), 2011-2013
Table 7-12: Hartmann Group – Strengths and Weaknesses
Table 7-13: Derma Sciences – Key Financials (Million US$), 2011-2013
Table 7-14: Derma Sciences – Strengths and Weaknesses
Table 7-15: Integra LifeSciences – Key Financials (Million US$), 2011-2013
Table 7-16: Integra LifeSciences – Strengths and Weaknesses